News from The Debiopharm Group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

08 Oct, 2007, 01:00 ET Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award

LAUSANNE, Switzerland, October 8 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...


11 Sep, 2007, 01:00 ET Debiopharm Receives cGMP Certification for Quality Control of its Drug Products

LAUSANNE, Switzerland, September 11 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist...


30 Aug, 2007, 01:00 ET The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience

LAUSANNE, Switzerland, August 30 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...


11 Jun, 2007, 01:00 ET Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease

LAUSANNE, Switzerland, June 11 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...


19 Apr, 2007, 01:00 ET Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment of HCV

LAUSANNE, Switzerland, April 19 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in...


27 Feb, 2007, 00:00 ET Clinical Update - Debio-9902 SR (ZT-1) Implant for Alzheimer's Disease

LAUSANNE, Switzerland, February 27 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...


20 Nov, 2006, 00:00 ET 2006 Mauvernay Research Excellence Award

LAUSANNE, Switzerland, November 20 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...


31 Oct, 2006, 00:00 ET Debiopharm Presents New Data Confirming Anti-HCV Activity of Cyclophilin Inhibitor Debio-025

LAUSANNE, Switzerland, October 31 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...


23 Oct, 2006, 01:00 ET Debiopharm Signs International License Agreements for Sanvar(R)

LAUSANNE, Switzerland, October 23 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...


16 Oct, 2006, 01:00 ET Debiopharm and Cambridge Antibody Technology Enter Into an Exclusive Agreement to Develop and Market SC-1 for Gastric Carcinomas

LAUSANNE, Switzerland, and CAMBRIDGE, England, October 16 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent...


11 Oct, 2006, 01:00 ET Debiopharm and EPFL Honour Dr Eduard Batlle With the 'Debiopharm Life Sciences Award'

LAUSANNE, Switzerland, October 11 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...


21 Sep, 2006, 01:00 ET Debiopharm Granted European Orphan Drug Status for Debio-0513 (PTR-262) for Myasthenia Gravis

LAUSANNE, Switzerland, September 21 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development...


27 Jun, 2006, 01:00 ET Debiopharm and Aurigene Enter into Agreement to Identify and Develop Selective Compounds for Immuno-Oncology Targets

LAUSANNE, Switzerland, and BANGALORE, India, June 27 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical...


20 Jun, 2006, 01:00 ET Moapar(R) 3 Months Approved for the Lowering of Testosterone to Castrate Serum Levels for Control of Sexual Drive in Adult Men

LAUSANNE, Switzerland, June 20 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...


14 Jun, 2006, 01:00 ET The Debiopharm Group and Sigma-Tau Sign R&D and Commercial Agreement for Istaroxime in Acute Heart Failure Syndromes

LAUSANNE, Switzerland, June 14 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company...


01 Jun, 2006, 01:00 ET The Debiopharm Group to Initiate Confirmatory Phase III Trial for Sanvar(R) in Esophageal Variceal Bleeding

LAUSANNE, Switzerland, June 1 /PRNewswire/ -- The Debiopharm Group, a global independent biopharmaceutical development company specialising in...